Basenko E, Kamei M, Ji L, Schmitz R, Lewis Z
PLoS Genet. 2016; 12(1):e1005790.
PMID: 26771905
PMC: 4714748.
DOI: 10.1371/journal.pgen.1005790.
Basenko E, Sasaki T, Ji L, Prybol C, Burckhardt R, Schmitz R
Proc Natl Acad Sci U S A. 2015; 112(46):E6339-48.
PMID: 26578794
PMC: 4655558.
DOI: 10.1073/pnas.1511377112.
Schroeder B, Ghare M, Bhattacharya C, Paul R, Yu Z, Zaleski P
J Am Chem Soc. 2014; 136(39):13641-56.
PMID: 25184545
PMC: 4183664.
DOI: 10.1021/ja507255g.
Hurt M, Beaudet A, Moses R
Proc Natl Acad Sci U S A. 1983; 80(22):6987-91.
PMID: 6196782
PMC: 390111.
DOI: 10.1073/pnas.80.22.6987.
Mirabelli C, Huang C, Prestayko A, Crooke S
Cancer Chemother Pharmacol. 1982; 8(1):57-65.
PMID: 6178526
DOI: 10.1007/BF00292872.
Comparison of the response of synchronized HeLa cells to talisomycin and bleomycin.
Mirabelli C, Crooke S
Cancer Chemother Pharmacol. 1981; 5(4):251-6.
PMID: 6167377
DOI: 10.1007/BF00434393.
[Bleomycin: effects on DNA and nuclear strucutre in mouse-fibroblasts (author's transl)].
Mittermayer C, Osieka R, Madreiter H
Arch Dermatol Forsch. 1974; 249(4):401-10.
PMID: 4135200
Anti-mitotic activity of bleomycin: time of action in the mammalian cell cycle.
Wheatley D, Mueller G, Kajiwara K
Br J Cancer. 1974; 29(2):117-31.
PMID: 4133781
PMC: 2008994.
DOI: 10.1038/bjc.1974.48.
Characterization of bleomycin-resistant DNA.
Kuo M, HAIDLE C, Inners L
Biophys J. 1973; 13(12):1296-306.
PMID: 4128368
PMC: 1484354.
DOI: 10.1016/s0006-3495(73)86063-1.
Further characterization of bleomycin-resistant HeLa cells and analysis of resistance mechanism.
Urade M, Sugi M, Matsuya T
Jpn J Cancer Res. 1988; 79(4):491-500.
PMID: 2454906
PMC: 5917510.
DOI: 10.1111/j.1349-7006.1988.tb01618.x.
Model for regulation of Escherichia coli DNA repair functions.
Gudas L, Pardee A
Proc Natl Acad Sci U S A. 1975; 72(6):2330-4.
PMID: 1094463
PMC: 432751.
DOI: 10.1073/pnas.72.6.2330.
Absence of strand breaks in deoxyribonucleic acid treated with metronidazole.
Larusso N, Tomasz M, KAPLAN D, Muller M
Antimicrob Agents Chemother. 1978; 13(1):19-24.
PMID: 626487
PMC: 352178.
DOI: 10.1128/AAC.13.1.19.
Degradation of Escherichia coli DNA: evidence for limitation in vivo by protein X, the recA gene product.
Satta G, Gudas L, Pardee A
Mol Gen Genet. 1979; 168(1):69-80.
PMID: 372741
DOI: 10.1007/BF00267935.
Noncovalent intermolecular crosslinks are produced by bleomycin reaction with duplex DNA.
Lloyd R, HAIDLE C, Robberson D
Proc Natl Acad Sci U S A. 1979; 76(6):2674-8.
PMID: 88734
PMC: 383670.
DOI: 10.1073/pnas.76.6.2674.
Bleomycin: effect on satellite DNA in mouse fibroblasts.
Madreiter H, Osieka R, Wittekind C, Kaden P, Mittermayer C
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1978; 92(3):309-13.
PMID: 83055
DOI: 10.1007/BF00461654.
Sequence specific cleavage of DNA by the antitumor antibiotics neocarzinostatin and bleomycin.
DAndrea A, Haseltine W
Proc Natl Acad Sci U S A. 1978; 75(8):3608-12.
PMID: 80799
PMC: 392834.
DOI: 10.1073/pnas.75.8.3608.
Early events and mechanisms in the induction of bacterial SOS functions: analysis of the phage repressor inactivation process in vivo.
Smith C, Oishi M
Proc Natl Acad Sci U S A. 1978; 75(4):1657-61.
PMID: 77015
PMC: 392397.
DOI: 10.1073/pnas.75.4.1657.
DNA double-strand breaks and alkali-labile bonds produced by bleomycin.
Povirk L, Wubter W, Kohnlein W, Hutchinson F
Nucleic Acids Res. 1977; 4(10):3573-80.
PMID: 73164
PMC: 342673.
DOI: 10.1093/nar/4.10.3573.
Combined effects of bleomycin and X-rays on DNA synthesis in asynchronous Ehrlich ascites cells in suspension.
Alalawi F, CHAPMAN I
Br J Cancer. 1977; 36(1):78-83.
PMID: 70209
PMC: 2025433.
DOI: 10.1038/bjc.1977.157.
Comparative studies of the incorporation inhibition of radioactive nucleotides and amino acids in vitro under the influence of adriamycin, bleomycin, and sodium arsenate.
Peters J, Baron D, Kiefer G, Glaesener J, Hug J, Hagedorn M
Arch Dermatol Res (1975). 1976; 257(2):185-94.
PMID: 64130
DOI: 10.1007/BF00558092.
